BP 955 (CPM-12 chlorpheniramine 12 mg)
Pill imprint BP 955 has been identified as CPM-12 chlorpheniramine 12 mg.
Chlorpheniramine is used in the treatment of urticaria; allergic rhinitis; cold symptoms; allergic reactions and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Chlorpheniramine chlorpheniramine 12 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- BP 955
- Strength:
- chlorpheniramine 12 mg
- Color:
- Clear / White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Antihistamines
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Brighton Pharma
- National Drug Code (NDC):
- 10914-0955
More about chlorpheniramine
Consumer resources
- Chlorpheniramine
- Chlorpheniramine controlled-release capsules
- Chlorpheniramine suspension
- Chlorpheniramine suspension drops
- Chlorpheniramine sustained-release capsules
- Chlorpheniramine syrup
- Other brands: Chlor-Trimeton, Allergy Relief, Aller-Chlor, Wal-finate, More (9) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
